enVVeno Medical (NVNO) Long-Term Debt Issuances (2017 - 2018)

enVVeno Medical's (NVNO) quarterly Long-Term Debt Issuances came in at -$601636.0 in Q4 2018, down 118.89% year-on-year from $3.2 million in Q4 2017, and up 68.02% quarter-over-quarter from -$1.9 million in Q2 2018.

enVVeno Medical (NVNO) Long-Term Debt Issuances (2017 - 2018) Analysis & Trends

enVVeno Medical's Long-Term Debt Issuances history runs 2 years deep, the most recent figure standing at -$601636.0 for Q4 2018.

  • On a quarterly basis, Long-Term Debt Issuances fell 118.89% year-over-year to -$601636.0 in Q4 2018; TTM through Dec 2020 was -$601636.0, a N/A change from a year earlier, with the FY2020 full-year figure at $312700.0, changed N/A from the prior year.
  • Long-Term Debt Issuances grew to -$601636.0 in Q4 2018 per NVNO's latest filing, from -$1.9 million in the prior quarter.
  • Across five years, Long-Term Debt Issuances topped out at $3.2 million in Q4 2017 and bottomed at -$1.9 million in Q2 2018.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Long-Term Debt Issuances (Qtr)
1 Abbott Laboratories 201.40 Bn 194.75 Bn 6.27 Bn 19.86 Bn
2 Stryker 122.29 Bn 119.41 Bn 3.81 Bn -
3 Medtronic 105.01 Bn 96.40 Bn 6.41 Bn -
4 Boston Scientific 64.81 Bn 63.59 Bn 3.61 Bn -
5 Edwards Lifesciences 55.28 Bn 51.60 Bn 1.29 Bn -
6 Dexcom 29.06 Bn 27.94 Bn 750.30 Mn -
7 Koninklijke Philips 29.02 Bn 25.93 Bn 2.07 Bn 11.71 Mn
8 GE HealthCare Technologies 28.27 Bn 26.20 Bn 1.98 Bn 1.15 Bn
9 Smith & Nephew 25.80 Bn 25.22 Bn - -
10 enVVeno Medical 2.75 Mn 2.75 Mn - -

Historic Data

Download Data
DateValue
Dec 31, 2018 -601,636.00
Dec 31, 2018 -601,636.00
Jun 30, 2018 -1.88 Mn
Jun 30, 2018 -1.88 Mn
Mar 31, 2018 2.60 Mn
Mar 31, 2018 2.60 Mn
Dec 31, 2017 3.18 Mn
Dec 31, 2017 3.18 Mn
Sep 30, 2017 2.33 Mn
Sep 30, 2017 2.33 Mn